Rapport Therapeutics, Inc. (RAPP)

Healthcare · Biotechnology · NASDAQ

Rapport Therapeutics, Inc. (RAPP) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.18B and a free-cash-flow yield of -5.0%.

Market cap	$2.18B
Trailing P/E	—
FCF yield	-5.0%
Revenue growth (YoY)	—
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live RAPP data on Nama Insights →